KLT-13466-86575
2 vaccinations
1 coded response
6 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 064 / CT
- Registered
- 2021-01-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Dose 1 — Moderna
-
2021-01-22
Registered in v-safe
-
2021-01-22
Survey response — day 21, dose 1MedDRA: Rash, SARS-CoV-2 test negative, Urticaria — Feeling: Good · Be unable to workFree text: Developed a hives like rash over 70% of my body on 1/16/21 that improved after 2 days. I had 2 negative covid test results 2 days after developing the rashMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-22
-
2021-01-27
Dose 2 — Moderna
-
2021-01-28
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-01-29
- 2021-01-31
- 2021-02-01
- 2021-03-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Moderna | |
| 2 | 2021-01-27 | Moderna |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 2 — day 21, dose 1
Symptoms: Developed a hives like rash over 70% of my body on 1/16/21 that improved after 2 days. I had 2 negative covid test results 2 days after developing the rash
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Rash | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | ✓ | ✓ |
| SD | Urticaria | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release